The P2RX7 polymorphism rs2230912 is associated with depression: A meta-analysis

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Single nucleotide polymorphisms (SNPs) in the P2RX7 gene, specifically rs2230912, have been investigated for associations with mood disorders.
• Previous research and meta-analyses yielded conflicting results, with some studies reporting associations and others finding none.

Purpose of the Study:

• To conduct a comprehensive meta-analysis including new data to re-evaluate the association between the P2RX7 rs2230912 SNP and mood disorders.
• To investigate the association stratified by specific mood disorders, major depressive disorder (MDD) and bipolar disorder (BD).

Main Methods:

• A meta-analysis was performed on data from 8,652 cases and 11,153 controls, incorporating unpublished results from the Munich Antidepressant Response Signature (MARS) study.
• Statistical models including allelic, dominant, and heterozygous-disadvantage models were used.
• Stratification analysis was conducted for MDD and BD subgroups.

Main Results:

• A significant association was found between rs2230912 and combined mood disorders (MDD or BD) across multiple genetic models, meeting stringent statistical thresholds.
• Stratification revealed a significant association for MDD (OR 1.12, allelic model).
• The association for BD showed a smaller effect size (OR 1.05) and did not reach statistical significance.

Conclusions:

• The P2RX7 rs2230912 SNP is significantly associated with combined mood disorders and specifically with major depressive disorder.
• The P2RX7 receptor's presence in the brain and immune cells suggests a potential role in mood disorder etiology.
• Further animal and functional studies are warranted to elucidate the precise mechanisms and potential therapeutic applications.